Literature DB >> 11272094

Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds.

L M Maciel1, S S Rodrigues, R S Dibbern, P A Navarro, E A Donadi.   

Abstract

Graves' disease (GD) is the most frequent cause of hyperthyroidism. Although the etiology is not completely elucidated, there are several lines of evidence suggesting multifactorial mechanisms. Genetic, constitutional, and environmental factors are involved in its pathogenesis. Major histocompatibility complex (MHC) class II alleles have been associated with GD in several populations of distinct ethnic backgrounds and there is increasing evidence supporting an association between GD and HLA-DR3 in Caucasian populations. The MHC class II alleles were evaluated in 75 Brazilian patients presenting with GD and in 166 control individuals from the same geographic area. HLA-DRB, DQB, and DQA alleles were identified using polymerase chain reaction (PCR)-amplified DNA hybridized with sequence-specific probes. The HLA-DRB1*0301 allele was significantly increased in patients (34/75, 45.3%) as compared with controls (37/166, 22.3%, p = 0.009), conferring a relative risk (RR) of 2.8 and an etiologic fraction (EF) of 0.287. The HLA-DQA1*0501 allele was also overrepresented in patients (48/71, 67.6%) in relation to controls (24/71, 33.8%; p = 0.004), conferring an RR of 3.74 and an EF of 0.351. The susceptibility conferred by HLA-DQA1*0501 was independent of the HLA-DRB1*0301 allele. On the other hand, the HLA-DQB1*0602 allele was significantly decreased in patients (6/75, 8.0%) in relation to controls (53/166, 31.9%, p = 0.0008), conferring an RR of 0.18 and a preventive fraction of 0.267. Although the Brazilian population comprises individuals of several ethnic backgrounds, these results corroborate the participation of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles as susceptibility markers for GD, and emphasize the participation of the HLA-DQB1*0602 allele as conferring protection against the development of the disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11272094     DOI: 10.1089/10507250150500630

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  15 in total

1.  Euthyroid Graves' ophthalmopathy with negative autoantibodies.

Authors:  Mehtap Cakir
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

2.  Genetics of autoimmune thyroid disease in the Lebanese population.

Authors:  C Farra; J Awwad; A Fadlallah; G Sebaly; G Hage; M Souaid; H Ashkar; R Medlej; M H Gannageh; G Halaby
Journal:  J Community Genet       Date:  2012-03-06

Review 3.  Cutting edge: the etiology of autoimmune thyroid diseases.

Authors:  Deirdre Cocks Eschler; Alia Hasham; Yaron Tomer
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

4.  Spontaneous lupus-like syndrome in HLA-DQ2 transgenic mice with a mixed genetic background.

Authors:  S Rashtak; E Marietta; S Cheng; M Camilleri; M Pittelkow; C David; J Grande; J Murray
Journal:  Lupus       Date:  2010-02-08       Impact factor: 2.911

5.  Graves' disease associated with anticardiolipin antibody positivity and acquired protein S deficiency.

Authors:  Tomohiro Nakayama; Tatsuo Yamamoto; Katsuo Kanmatsuse; Shinichiro Kokubun
Journal:  Rheumatol Int       Date:  2003-02-26       Impact factor: 2.631

Review 6.  The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology.

Authors:  Eric M Jacobson; Amanda Huber; Yaron Tomer
Journal:  J Autoimmun       Date:  2008-01-04       Impact factor: 7.094

7.  Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume?

Authors:  G Zettinig; A Tanew; G Fischer; W Mayr; R Dudczak; M Weissel
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

Review 8.  Unravelling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond.

Authors:  M J Simmonds; S C L Gough
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

9.  Dissecting the Genetic Susceptibility to Graves' Disease in a Cohort of Patients of Italian Origin.

Authors:  Angela Lombardi; Francesca Menconi; David Greenberg; Erlinda Concepcion; Marenza Leo; Roberto Rocchi; Michele Marinó; Mehdi Keddache; Yaron Tomer
Journal:  Front Endocrinol (Lausanne)       Date:  2016-03-08       Impact factor: 5.555

Review 10.  Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves' Disease.

Authors:  Hidefumi Inaba; Leslie J De Groot; Takashi Akamizu
Journal:  Front Endocrinol (Lausanne)       Date:  2016-08-23       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.